img

Global Candidiasis Drug Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Candidiasis Drug Market Insights, Forecast to 2034

The standard recommended dose for most Candida infections is fluconazole at 800 mg as the loading dose, followed by fluconazole at a dose of 400 mg/d either intravenously or orally for at least 2 weeks of therapy after a demonstrated negative blood culture result or clinical signs of improvement.
Market Analysis and InsightsGlobal Candidiasis Drug Market
Global Candidiasis Drug market is expected to reach to US$ 1221 million in 2024, with a positive growth of %, compared with US$ 1163 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Candidiasis Drug industry is evaluated to reach US$ 1617.6 million in 2029. The CAGR will be 4.8% during 2024 to 2029.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global Candidiasis Drug market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Candidiasis Drug market with multiple angles. Items like regional revenue from 2018 to 2029 and companies’ revenue and gross margin from 2018 to 2024 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Bayer
Perrigo
J & J
Pfizer
Bristol-Myers Squibb
Effik
Teva
Sanofi
Cisen Pharmaceutical
Kingyork Group
Segment by Type
Oral
External Use
Other

Segment by Application


Hospital
Retail Pharmacy
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2029
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2029 globally
Chapter 5Product revenue analysis by application from 2018 to 2029 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2029 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product revenue analysis by type and application from 2018 to 2029 in Europe. Product revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product revenue analysis by type and application from 2018 to 2029 in China. Product revenue analysis of China from 2018 to 2029
Chapter 9Product revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Companies’ outline, covering company’s basic information, major business, Candidiasis Drug introduction, etc. Candidiasis Drug Revenue and Gross Margin of each company from 2018 to 2024
Chapter 12Mr Accuracy reports Conclusions of Candidiasis Drug
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Candidiasis Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Oral
1.2.3 External Use
1.2.4 Other
1.3 Market by Application
1.3.1 Global Candidiasis Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Candidiasis Drug Market Perspective (2018-2029)
2.2 Global Candidiasis Drug Growth Trends by Region
2.2.1 Candidiasis Drug Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Candidiasis Drug Historic Market Size by Region (2018-2024)
2.2.3 Candidiasis Drug Forecasted Market Size by Region (2024-2029)
2.3 Candidiasis Drug Market Dynamics
2.3.1 Candidiasis Drug Industry Trends
2.3.2 Candidiasis Drug Market Drivers
2.3.3 Candidiasis Drug Market Challenges
2.3.4 Candidiasis Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Candidiasis Drug by Players
3.1.1 Global Candidiasis Drug Revenue by Players (2018-2024)
3.1.2 Global Candidiasis Drug Revenue Market Share by Players (2018-2024)
3.2 Global Candidiasis Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Candidiasis Drug, Ranking by Revenue, 2021 VS 2022 VS 2024
3.4 Global Candidiasis Drug Market Concentration Ratio
3.4.1 Global Candidiasis Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Candidiasis Drug Revenue in 2022
3.5 Global Key Players of Candidiasis Drug Head office and Area Served
3.6 Global Key Players of Candidiasis Drug, Product and Application
3.7 Global Key Players of Candidiasis Drug, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Candidiasis Drug Breakdown Data by Type
4.1 Global Candidiasis Drug Historic Market Size by Type (2018-2024)
4.2 Global Candidiasis Drug Forecasted Market Size by Type (2024-2029)
5 Candidiasis Drug Breakdown Data by Application
5.1 Global Candidiasis Drug Historic Market Size by Application (2018-2024)
5.2 Global Candidiasis Drug Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Candidiasis Drug Market Size (2018-2029)
6.2 North America Candidiasis Drug Market Size by Type
6.2.1 North America Candidiasis Drug Market Size by Type (2018-2024)
6.2.2 North America Candidiasis Drug Market Size by Type (2024-2029)
6.2.3 North America Candidiasis Drug Market Share by Type (2018-2029)
6.3 North America Candidiasis Drug Market Size by Application
6.3.1 North America Candidiasis Drug Market Size by Application (2018-2024)
6.3.2 North America Candidiasis Drug Market Size by Application (2024-2029)
6.3.3 North America Candidiasis Drug Market Share by Application (2018-2029)
6.4 North America Candidiasis Drug Market Size by Country
6.4.1 North America Candidiasis Drug Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Candidiasis Drug Market Size by Country (2018-2024)
6.4.3 North America Candidiasis Drug Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Candidiasis Drug Market Size (2018-2029)
7.2 Europe Candidiasis Drug Market Size by Type
7.2.1 Europe Candidiasis Drug Market Size by Type (2018-2024)
7.2.2 Europe Candidiasis Drug Market Size by Type (2024-2029)
7.2.3 Europe Candidiasis Drug Market Share by Type (2018-2029)
7.3 Europe Candidiasis Drug Market Size by Application
7.3.1 Europe Candidiasis Drug Market Size by Application (2018-2024)
7.3.2 Europe Candidiasis Drug Market Size by Application (2024-2029)
7.3.3 Europe Candidiasis Drug Market Share by Application (2018-2029)
7.4 Europe Candidiasis Drug Market Size by Country
7.4.1 Europe Candidiasis Drug Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Candidiasis Drug Market Size by Country (2018-2024)
7.4.3 Europe Candidiasis Drug Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Candidiasis Drug Market Size (2018-2029)
8.2 China Candidiasis Drug Market Size by Type
8.2.1 China Candidiasis Drug Market Size by Type (2018-2024)
8.2.2 China Candidiasis Drug Market Size by Type (2024-2029)
8.2.3 China Candidiasis Drug Market Share by Type (2018-2029)
8.3 China Candidiasis Drug Market Size by Application
8.3.1 China Candidiasis Drug Market Size by Application (2018-2024)
8.3.2 China Candidiasis Drug Market Size by Application (2024-2029)
8.3.3 China Candidiasis Drug Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Candidiasis Drug Market Size (2018-2029)
9.2 Asia Candidiasis Drug Market Size by Type
9.2.1 Asia Candidiasis Drug Market Size by Type (2018-2024)
9.2.2 Asia Candidiasis Drug Market Size by Type (2024-2029)
9.2.3 Asia Candidiasis Drug Market Share by Type (2018-2029)
9.3 Asia Candidiasis Drug Market Size by Application
9.3.1 Asia Candidiasis Drug Market Size by Application (2018-2024)
9.3.2 Asia Candidiasis Drug Market Size by Application (2024-2029)
9.3.3 Asia Candidiasis Drug Market Share by Application (2018-2029)
9.4 Asia Candidiasis Drug Market Size by Region
9.4.1 Asia Candidiasis Drug Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Candidiasis Drug Market Size by Region (2018-2024)
9.4.3 Asia Candidiasis Drug Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Candidiasis Drug Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Candidiasis Drug Market Size by Type
10.2.1 Middle East, Africa, and Latin America Candidiasis Drug Market Size by Type (2018-2024)
10.2.2 Middle East, Africa, and Latin America Candidiasis Drug Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Candidiasis Drug Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Candidiasis Drug Market Size by Application
10.3.1 Middle East, Africa, and Latin America Candidiasis Drug Market Size by Application (2018-2024)
10.3.2 Middle East, Africa, and Latin America Candidiasis Drug Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Candidiasis Drug Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Candidiasis Drug Market Size by Country
10.4.1 Middle East, Africa, and Latin America Candidiasis Drug Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Candidiasis Drug Market Size by Country (2018-2024)
10.4.3 Middle East, Africa, and Latin America Candidiasis Drug Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Bayer
11.1.1 Bayer Company Details
11.1.2 Bayer Business Overview
11.1.3 Bayer Candidiasis Drug Introduction
11.1.4 Bayer Revenue in Candidiasis Drug Business (2018-2024)
11.1.5 Bayer Recent Developments
11.2 Perrigo
11.2.1 Perrigo Company Details
11.2.2 Perrigo Business Overview
11.2.3 Perrigo Candidiasis Drug Introduction
11.2.4 Perrigo Revenue in Candidiasis Drug Business (2018-2024)
11.2.5 Perrigo Recent Developments
11.3 J & J
11.3.1 J & J Company Details
11.3.2 J & J Business Overview
11.3.3 J & J Candidiasis Drug Introduction
11.3.4 J & J Revenue in Candidiasis Drug Business (2018-2024)
11.3.5 J & J Recent Developments
11.4 Pfizer
11.4.1 Pfizer Company Details
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Candidiasis Drug Introduction
11.4.4 Pfizer Revenue in Candidiasis Drug Business (2018-2024)
11.4.5 Pfizer Recent Developments
11.5 Bristol-Myers Squibb
11.5.1 Bristol-Myers Squibb Company Details
11.5.2 Bristol-Myers Squibb Business Overview
11.5.3 Bristol-Myers Squibb Candidiasis Drug Introduction
11.5.4 Bristol-Myers Squibb Revenue in Candidiasis Drug Business (2018-2024)
11.5.5 Bristol-Myers Squibb Recent Developments
11.6 Effik
11.6.1 Effik Company Details
11.6.2 Effik Business Overview
11.6.3 Effik Candidiasis Drug Introduction
11.6.4 Effik Revenue in Candidiasis Drug Business (2018-2024)
11.6.5 Effik Recent Developments
11.7 Teva
11.7.1 Teva Company Details
11.7.2 Teva Business Overview
11.7.3 Teva Candidiasis Drug Introduction
11.7.4 Teva Revenue in Candidiasis Drug Business (2018-2024)
11.7.5 Teva Recent Developments
11.8 Sanofi
11.8.1 Sanofi Company Details
11.8.2 Sanofi Business Overview
11.8.3 Sanofi Candidiasis Drug Introduction
11.8.4 Sanofi Revenue in Candidiasis Drug Business (2018-2024)
11.8.5 Sanofi Recent Developments
11.9 Cisen Pharmaceutical
11.9.1 Cisen Pharmaceutical Company Details
11.9.2 Cisen Pharmaceutical Business Overview
11.9.3 Cisen Pharmaceutical Candidiasis Drug Introduction
11.9.4 Cisen Pharmaceutical Revenue in Candidiasis Drug Business (2018-2024)
11.9.5 Cisen Pharmaceutical Recent Developments
11.10 Kingyork Group
11.10.1 Kingyork Group Company Details
11.10.2 Kingyork Group Business Overview
11.10.3 Kingyork Group Candidiasis Drug Introduction
11.10.4 Kingyork Group Revenue in Candidiasis Drug Business (2018-2024)
11.10.5 Kingyork Group Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Candidiasis Drug Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Oral
Table 3. Key Players of External Use
Table 4. Key Players of Other
Table 5. Global Candidiasis Drug Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 6. Global Candidiasis Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Candidiasis Drug Market Size by Region (2018-2024) & (US$ Million)
Table 8. Global Candidiasis Drug Market Share by Region (2018-2024)
Table 9. Global Candidiasis Drug Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 10. Global Candidiasis Drug Market Share by Region (2024-2029)
Table 11. Candidiasis Drug Market Trends
Table 12. Candidiasis Drug Market Drivers
Table 13. Candidiasis Drug Market Challenges
Table 14. Candidiasis Drug Market Restraints
Table 15. Global Candidiasis Drug Revenue by Players (2018-2024) & (US$ Million)
Table 16. Global Candidiasis Drug Revenue Share by Players (2018-2024)
Table 17. Global Top Candidiasis Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Candidiasis Drug as of 2022)
Table 18. Global Candidiasis Drug Industry Ranking 2021 VS 2022 VS 2024
Table 19. Global 5 Largest Players Market Share by Candidiasis Drug Revenue (CR5 and HHI) & (2018-2024)
Table 20. Global Key Players of Candidiasis Drug, Headquarters and Area Served
Table 21. Global Key Players of Candidiasis Drug, Product and Application
Table 22. Global Key Players of Candidiasis Drug, Product and Application
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Candidiasis Drug Market Size by Type (2018-2024) & (US$ Million)
Table 25. Global Candidiasis Drug Revenue Market Share by Type (2018-2024)
Table 26. Global Candidiasis Drug Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 27. Global Candidiasis Drug Revenue Market Share by Type (2024-2029)
Table 28. Global Candidiasis Drug Market Size by Application (2018-2024) & (US$ Million)
Table 29. Global Candidiasis Drug Revenue Share by Application (2018-2024)
Table 30. Global Candidiasis Drug Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 31. Global Candidiasis Drug Revenue Share by Application (2024-2029)
Table 32. North America Candidiasis Drug Market Size by Type (2018-2024) & (US$ Million)
Table 33. North America Candidiasis Drug Market Size by Type (2024-2029) & (US$ Million)
Table 34. North America Candidiasis Drug Market Size by Application (2018-2024) & (US$ Million)
Table 35. North America Candidiasis Drug Market Size by Application (2024-2029) & (US$ Million)
Table 36. North America Candidiasis Drug Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 37. North America Candidiasis Drug Market Size by Country (2018-2024) & (US$ Million)
Table 38. North America Candidiasis Drug Market Size by Country (2024-2029) & (US$ Million)
Table 39. Europe Candidiasis Drug Market Size by Type (2018-2024) & (US$ Million)
Table 40. Europe Candidiasis Drug Market Size by Type (2024-2029) & (US$ Million)
Table 41. Europe Candidiasis Drug Market Size by Application (2018-2024) & (US$ Million)
Table 42. Europe Candidiasis Drug Market Size by Application (2024-2029) & (US$ Million)
Table 43. Europe Candidiasis Drug Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Europe Candidiasis Drug Market Size by Country (2018-2024) & (US$ Million)
Table 45. Europe Candidiasis Drug Market Size by Country (2024-2029) & (US$ Million)
Table 46. China Candidiasis Drug Market Size by Type (2018-2024) & (US$ Million)
Table 47. China Candidiasis Drug Market Size by Type (2024-2029) & (US$ Million)
Table 48. China Candidiasis Drug Market Size by Application (2018-2024) & (US$ Million)
Table 49. China Candidiasis Drug Market Size by Application (2024-2029) & (US$ Million)
Table 50. Asia Candidiasis Drug Market Size by Type (2018-2024) & (US$ Million)
Table 51. Asia Candidiasis Drug Market Size by Type (2024-2029) & (US$ Million)
Table 52. Asia Candidiasis Drug Market Size by Application (2018-2024) & (US$ Million)
Table 53. Asia Candidiasis Drug Market Size by Application (2024-2029) & (US$ Million)
Table 54. Asia Candidiasis Drug Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 55. Asia Candidiasis Drug Market Size by Region (2018-2024) & (US$ Million)
Table 56. Asia Candidiasis Drug Market Size by Region (2024-2029) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Candidiasis Drug Market Size by Type (2018-2024) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Candidiasis Drug Market Size by Type (2024-2029) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Candidiasis Drug Market Size by Application (2018-2024) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Candidiasis Drug Market Size by Application (2024-2029) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Candidiasis Drug Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 62. Middle East, Africa, and Latin America Candidiasis Drug Market Size by Country (2018-2024) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Candidiasis Drug Market Size by Country (2024-2029) & (US$ Million)
Table 64. Bayer Company Details
Table 65. Bayer Business Overview
Table 66. Bayer Candidiasis Drug Product
Table 67. Bayer Revenue in Candidiasis Drug Business (2018-2024) & (US$ Million)
Table 68. Bayer Recent Developments
Table 69. Perrigo Company Details
Table 70. Perrigo Business Overview
Table 71. Perrigo Candidiasis Drug Product
Table 72. Perrigo Revenue in Candidiasis Drug Business (2018-2024) & (US$ Million)
Table 73. Perrigo Recent Developments
Table 74. J & J Company Details
Table 75. J & J Business Overview
Table 76. J & J Candidiasis Drug Product
Table 77. J & J Revenue in Candidiasis Drug Business (2018-2024) & (US$ Million)
Table 78. J & J Recent Developments
Table 79. Pfizer Company Details
Table 80. Pfizer Business Overview
Table 81. Pfizer Candidiasis Drug Product
Table 82. Pfizer Revenue in Candidiasis Drug Business (2018-2024) & (US$ Million)
Table 83. Pfizer Recent Developments
Table 84. Bristol-Myers Squibb Company Details
Table 85. Bristol-Myers Squibb Business Overview
Table 86. Bristol-Myers Squibb Candidiasis Drug Product
Table 87. Bristol-Myers Squibb Revenue in Candidiasis Drug Business (2018-2024) & (US$ Million)
Table 88. Bristol-Myers Squibb Recent Developments
Table 89. Effik Company Details
Table 90. Effik Business Overview
Table 91. Effik Candidiasis Drug Product
Table 92. Effik Revenue in Candidiasis Drug Business (2018-2024) & (US$ Million)
Table 93. Effik Recent Developments
Table 94. Teva Company Details
Table 95. Teva Business Overview
Table 96. Teva Candidiasis Drug Product
Table 97. Teva Revenue in Candidiasis Drug Business (2018-2024) & (US$ Million)
Table 98. Teva Recent Developments
Table 99. Sanofi Company Details
Table 100. Sanofi Business Overview
Table 101. Sanofi Candidiasis Drug Product
Table 102. Sanofi Revenue in Candidiasis Drug Business (2018-2024) & (US$ Million)
Table 103. Sanofi Recent Developments
Table 104. Cisen Pharmaceutical Company Details
Table 105. Cisen Pharmaceutical Business Overview
Table 106. Cisen Pharmaceutical Candidiasis Drug Product
Table 107. Cisen Pharmaceutical Revenue in Candidiasis Drug Business (2018-2024) & (US$ Million)
Table 108. Cisen Pharmaceutical Recent Developments
Table 109. Kingyork Group Company Details
Table 110. Kingyork Group Business Overview
Table 111. Kingyork Group Candidiasis Drug Product
Table 112. Kingyork Group Revenue in Candidiasis Drug Business (2018-2024) & (US$ Million)
Table 113. Kingyork Group Recent Developments
Table 114. Research Programs/Design for This Report
Table 115. Key Data Information from Secondary Sources
Table 116. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Candidiasis Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Candidiasis Drug Market Share by Type: 2022 VS 2029
Figure 3. Oral Features
Figure 4. External Use Features
Figure 5. Other Features
Figure 6. Global Candidiasis Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Candidiasis Drug Market Share by Application: 2022 VS 2029
Figure 8. Hospital Case Studies
Figure 9. Retail Pharmacy Case Studies
Figure 10. Other Case Studies
Figure 11. Candidiasis Drug Report Years Considered
Figure 12. Global Candidiasis Drug Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 13. Global Candidiasis Drug Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Candidiasis Drug Market Share by Region: 2022 VS 2029
Figure 15. Global Candidiasis Drug Market Share by Players in 2022
Figure 16. Global Top Candidiasis Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Candidiasis Drug as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Candidiasis Drug Revenue in 2022
Figure 18. North America Candidiasis Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. North America Candidiasis Drug Market Share by Type (2018-2029)
Figure 20. North America Candidiasis Drug Market Share by Application (2018-2029)
Figure 21. North America Candidiasis Drug Market Share by Country (2018-2029)
Figure 22. United States Candidiasis Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Canada Candidiasis Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Candidiasis Drug Market Size YoY (2018-2029) & (US$ Million)
Figure 25. Europe Candidiasis Drug Market Share by Type (2018-2029)
Figure 26. Europe Candidiasis Drug Market Share by Application (2018-2029)
Figure 27. Europe Candidiasis Drug Market Share by Country (2018-2029)
Figure 28. Germany Candidiasis Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. France Candidiasis Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. U.K. Candidiasis Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Italy Candidiasis Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Russia Candidiasis Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Nordic Countries Candidiasis Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. China Candidiasis Drug Market Size YoY (2018-2029) & (US$ Million)
Figure 35. China Candidiasis Drug Market Share by Type (2018-2029)
Figure 36. China Candidiasis Drug Market Share by Application (2018-2029)
Figure 37. Asia Candidiasis Drug Market Size YoY (2018-2029) & (US$ Million)
Figure 38. Asia Candidiasis Drug Market Share by Type (2018-2029)
Figure 39. Asia Candidiasis Drug Market Share by Application (2018-2029)
Figure 40. Asia Candidiasis Drug Market Share by Region (2018-2029)
Figure 41. Japan Candidiasis Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. South Korea Candidiasis Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. China Taiwan Candidiasis Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Southeast Asia Candidiasis Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. India Candidiasis Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Australia Candidiasis Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Candidiasis Drug Market Size YoY (2018-2029) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Candidiasis Drug Market Share by Type (2018-2029)
Figure 49. Middle East, Africa, and Latin America Candidiasis Drug Market Share by Application (2018-2029)
Figure 50. Middle East, Africa, and Latin America Candidiasis Drug Market Share by Country (2018-2029)
Figure 51. Brazil Candidiasis Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Mexico Candidiasis Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Turkey Candidiasis Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Saudi Arabia Candidiasis Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Israel Candidiasis Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. GCC Countries Candidiasis Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 57. Bayer Revenue Growth Rate in Candidiasis Drug Business (2018-2024)
Figure 58. Perrigo Revenue Growth Rate in Candidiasis Drug Business (2018-2024)
Figure 59. J & J Revenue Growth Rate in Candidiasis Drug Business (2018-2024)
Figure 60. Pfizer Revenue Growth Rate in Candidiasis Drug Business (2018-2024)
Figure 61. Bristol-Myers Squibb Revenue Growth Rate in Candidiasis Drug Business (2018-2024)
Figure 62. Effik Revenue Growth Rate in Candidiasis Drug Business (2018-2024)
Figure 63. Teva Revenue Growth Rate in Candidiasis Drug Business (2018-2024)
Figure 64. Sanofi Revenue Growth Rate in Candidiasis Drug Business (2018-2024)
Figure 65. Cisen Pharmaceutical Revenue Growth Rate in Candidiasis Drug Business (2018-2024)
Figure 66. Kingyork Group Revenue Growth Rate in Candidiasis Drug Business (2018-2024)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries